Current Research Studies

Cancer – ALTE1621: Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure: a Phase 2b Randomized Placebo-Controlled Trial

Condition or Therapy:



Cancer and Blood Disorders
Study Number: ALTE1621

What is the goal of this study?

Researchers want to know how well low-dose carvedilol works in preventing heart failure in cancer survivors exposed to high dose anthracyclines.

Who can join the study?

This study may be a good fit for children and young adults who:

  • are any age,
  • weigh greater than 40 kg (approx. 88 lbs),
  • had a cancer diagnosis under the age of 22, and
  • have completed cancer treatment.

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Eric Chow